Evidence map›Paper›PMID 28724563›Full record

ReviewEuropean respiratory review : an official journal of the European Respiratory Society2017

Management of anticoagulant and antiplatelet therapy in patients undergoing interventional pulmonary procedures.

Vikas Pathak, J Erin Allender, Mollie W Grant

Open access · diamondAbstract readReview
In one paragraph

Review in European respiratory review : an official journal of the European Respiratory Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Pharmacological approach to iatrogenic bleeding during bronchoscopy: what do we know so far and where do we go from here?Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2023
    Article
  12. Review
  13. Managing complications of pleural procedures.Journal of thoracic disease · 2021
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Consensus on the digestive endoscopic tunnel technique.World journal of gastroenterology · 2019
    Article
  19. Review
  20. Survey of management of iatrogenic bleeding following bronchoscopic sampling.European respiratory review : an official journal of the European Respiratory Society · 2018
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Vikas PathakDept of Pulmonary Disease and Critical Care Medicine, WakeMed Health and Hospitals, Raleigh, NC, USA drvikaspathak@gmail.com.
J Erin AllenderDept of Pharmacy, WakeMed Health and Hospitals, Raleigh, NC, USA.
Mollie W GrantDept of Pharmacy, WakeMed Health and Hospitals, Raleigh, NC, USA.
WakeMed · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There has been great progress in antithrombotic therapy over the past several years. Its use has increased with the advent of novel anticoagulants, as these medications do not require frequent blood tests for monitoring. Antithrombotic therapy is aimed at reducing the risk of thromboembolic events in patients with atrial fibrillation, coronary artery disease, deep vein thrombosis, valvular heart disease and pulmonary embolism. These patients are often critically ill and frequently undergo urgent interventions requiring discontinuation of anticoagulant or antiplatelet therapy which can increase the risk of thrombosis; however, continuing these agents can lead to increased risk of haemorrhage.The purpose of this article is to summarise the literature surrounding the safety of using antiplatelet and anticoagulant therapies in patients undergoing interventional pulmonary procedures.

Indexed as

AnticoagulantsDrug Administration ScheduleFibrinolytic AgentsHemorrhageHumansPlatelet Aggregation InhibitorsRisk FactorsSpecimen HandlingThoracic Surgical ProceduresAnticoagulantsFibrinolytic AgentsPlatelet Aggregation Inhibitors

Identifiers

PMID28724563
PMCPMC9488580
OpenAlexW2736827012

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.